Cargando…
CRISPR-Cas9–Mediated TIM3 Knockout in Human Natural Killer Cells Enhances Growth Inhibitory Effects on Human Glioma Cells
Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumor in adults. Natural Killer (NK) cells are potent cytotoxic effector cells against tumor cells inducing GBM cells; therefore, NK cell based- immunotherapy might be a promising target in GBM. T cell immunoglobulin mucin...
Autores principales: | Morimoto, Takayuki, Nakazawa, Tsutomu, Matsuda, Ryosuke, Nishimura, Fumihiko, Nakamura, Mitsutoshi, Yamada, Shuichi, Nakagawa, Ichiro, Park, Young-Soo, Tsujimura, Takahiro, Nakase, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036491/ https://www.ncbi.nlm.nih.gov/pubmed/33800561 http://dx.doi.org/10.3390/ijms22073489 |
Ejemplares similares
-
CIS deletion by CRISPR/Cas9 enhances human primary natural killer cell functions against allogeneic glioblastoma
por: Nakazawa, Tsutomu, et al.
Publicado: (2023) -
Establishment of an efficient ex vivo expansion strategy for human natural killer cells stimulated by defined cytokine cocktail and antibodies against natural killer cell activating receptors
por: Nakazawa, Tsutomu, et al.
Publicado: (2022) -
An efficient feeder-free and chemically-defined expansion strategy for highly purified natural killer cells derived from human cord blood
por: Nakazawa, Tsutomu, et al.
Publicado: (2023) -
Effect of CRISPR/Cas9-Mediated PD-1-Disrupted Primary Human Third-Generation CAR-T Cells Targeting EGFRvIII on In Vitro Human Glioblastoma Cell Growth
por: Nakazawa, Tsutomu, et al.
Publicado: (2020) -
Therapeutic Anti-KIR Antibody of 1–7F9 Attenuates the Antitumor Effects of Expanded and Activated Human Primary Natural Killer Cells on In Vitro Glioblastoma-like Cells and Orthotopic Tumors Derived Therefrom
por: Maeoka, Ryosuke, et al.
Publicado: (2023)